No CDKN2A mutations were identified in G500 heterozygotes as evident by dHPLC and sequence analysis of all CDKN2A exons and exon/intron boundaries in amplicons of tumor and blood leukocyte extracted DNA. The gene discussed is CDKN2A; the disease is neoplasm.